The nation's mental health is under strain.
The pressures of isolation, joblessness, and uncertainty have already seen an upsurge in rates of depression and anxiety.
Common treatments include therapy and medication, but what if there was a third arrow in this quiver?
The Epworth Centre for Innovation in Mental Health is using Transcranial Alternating Current Stimulation to find out whether it's effective in treating people with OCD, anxiety and depression, and the results, so far, are promising.
Their goal is to get approval for pre-programmed TACS caps to be available under medical supervision across the country, to people who find access to treatment difficult due to age or location.
If you're aged between 16 and 30, and have symptoms of, or have been diagnosed with, depression, you may be eligible to participate.
This is the link to the trial criteria.
Guests:
Clair, clinical trial participant
Paul Fitzgerald, Professor of Psychiatry and Director of the Epworth Centre for Innovation in Mental Health
Credits
In this episode